BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36907105)

  • 21. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer.
    Lee SJ; Lee I; Lee J; Park C; Kang WK
    Br J Cancer; 2014 Jul; 111(3):497-505. PubMed ID: 24945998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.
    Kamel WA; Sugihara E; Nobusue H; Yamaguchi-Iwai S; Onishi N; Maki K; Fukuchi Y; Matsuo K; Muto A; Saya H; Shimizu T
    Mol Cancer Ther; 2017 Jan; 16(1):182-192. PubMed ID: 27799356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential use of simvastatin for cancer treatment: A review.
    Duarte JA; de Barros ALB; Leite EA
    Biomed Pharmacother; 2021 Sep; 141():111858. PubMed ID: 34323700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-κB signalling participate in anti-glioblastoma of imipramine.
    Hsu FT; Chiang IT; Wang WS
    J Cell Mol Med; 2020 Apr; 24(7):3982-4000. PubMed ID: 32149465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase.
    Koyuturk M; Ersoz M; Altiok N
    Neurosci Lett; 2004 Nov; 370(2-3):212-7. PubMed ID: 15488325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
    Zhang R; Banik NL; Ray SK
    Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins Inhibit Toll-Like Receptor 4-Mediated Growth of Human Esophageal Adenocarcinoma Cells.
    Gergen AK; Kohtz PD; Halpern AL; White AM; Meng X; Fullerton DA; Weyant MJ
    J Surg Res; 2021 Apr; 260():436-447. PubMed ID: 33272595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin reduces melanoma progression in a murine model.
    Zanfardino M; Spampanato C; De Cicco R; Buommino E; De Filippis A; Baiano S; Barra A; Morelli F
    Int J Oncol; 2013 Dec; 43(6):1763-70. PubMed ID: 24101161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
    Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
    ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia.
    Moreau AS; Jia X; Patterson CJ; Roccaro AM; Xu L; Sacco A; O'Connor K; Soumerai J; Ngo HT; Hatjiharissi E; Hunter ZR; Ciccarelli B; Manning R; Ghobrial IM; Leleu X; Treon SP
    Br J Haematol; 2008 Sep; 142(5):775-85. PubMed ID: 18537966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin.
    Misirkic M; Janjetovic K; Vucicevic L; Tovilovic G; Ristic B; Vilimanovich U; Harhaji-Trajkovic L; Sumarac-Dumanovic M; Micic D; Bumbasirevic V; Trajkovic V
    Pharmacol Res; 2012 Jan; 65(1):111-9. PubMed ID: 21871960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells.
    Pelaia G; Gallelli L; Renda T; Fratto D; Falcone D; Caraglia M; Busceti MT; Terracciano R; Vatrella A; Maselli R; Savino R
    Cell Prolif; 2012 Dec; 45(6):557-65. PubMed ID: 23045963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.
    Borahay MA; Vincent K; Motamedi M; Sbrana E; Kilic GS; Al-Hendy A; Boehning D
    Am J Obstet Gynecol; 2015 Aug; 213(2):196.e1-8. PubMed ID: 25840272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
    Sun FR; Wang SL; Wang M; Sun LM
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6726-6734. PubMed ID: 32633363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
    Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
    Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial.
    Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4938-45. PubMed ID: 19890022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
    Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
    Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.
    Stine JE; Guo H; Sheng X; Han X; Schointuch MN; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Jan; 7(1):946-60. PubMed ID: 26503475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer.
    Schointuch MN; Gilliam TP; Stine JE; Han X; Zhou C; Gehrig PA; Kim K; Bae-Jump VL
    Gynecol Oncol; 2014 Aug; 134(2):346-55. PubMed ID: 24880141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.